Print Page  Close Window

2017 Press Releases

Keyword Search
 
Current | Archive
DateTitle 
06/22/17OraSure Technologies Appoints Mara G. Aspinall to Board of Directors
BETHLEHEM, Pa., June 22, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced the appointment of Ms. Mara G. Aspinall as a member of the Company's Board of Directors.  Ms. Aspinall will serve as a Class II Director with an initial term expiring at the Company’s 2020 Annual Meeting of Stockholders.  She will also serve on the Audit and Compensation Committees of the Board. "We are please... 
Printer Friendly Version
05/31/17OraSure Technologies to Present at the Jefferies 2017 Global Healthcare Conference
BETHLEHEM, Pa., May 31, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Jefferies 2017 Global Healthcare Conference in New York, New York.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on June 7, 2017, at approximately 8:30 AM Eastern Time ... 
Printer Friendly Version
05/16/17OraSure Technologies to Present at the UBS Global Healthcare Conference
BETHLEHEM, Pa., May 16, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the UBS Global Healthcare Conference in New York, New York.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on May 23, 2017, at approximately 8:30 AM Eastern Time (5:30 AM Pa... 
Printer Friendly Version
05/10/17OraSure Technologies to Hold Virtual Annual Meeting of Stockholders
BETHLEHEM, Pa., May 10, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), announced that its 2017 Annual Meeting of Stockholders will again be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time) on Tuesday, May 16, 2017. In order to access the meeting, interested parties may go to www.virtualshareholdermeeting.com/OSUR2017 five (5) minutes prior to the start of the meeting to log in.  Stockholders must enter ... 
Printer Friendly Version
05/03/17OraSure Announces 2017 First Quarter Financial Results
BETHLEHEM, Pa., May 03, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the first quarter ended March 31, 2017. Financial Highlights Consolidated net revenues for the first quarter of 2017 were $32.5 million, a 12% increase from the first quarter of 2016. Net product revenues were $31.5 million, representing a 25% increase over the first qu... 
Printer Friendly Version
04/12/17OraSure Technologies Earnings Conference Call Invitation
2017 First Quarter Earnings Conference Call Wednesday, May 3, 2017, 5:00 p.m. ET BETHLEHEM, Pa., April 12, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2017 First quarter financial results, 2017 second quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, May 3, 2017.      May 3, 2017 Schedule       4:00... 
Printer Friendly Version
03/01/17OraSure Receives Global Fund Classification to Enable HIV Self-Test Procurement
BETHLEHEM, Pa., March 01, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that its OraQuick® HIV Self-Test has been designated as eligible for procurement by purchasing entities entitled to access Global Fund and/or UNITAID resources.  The OraQuick® HIV Self-Test has been classified by the Global Fund’s Expert Review Panel for Diagnostics as CATEGORY-2. The classification facilitates... 
Printer Friendly Version
02/27/17OraSure Technologies to Present at the Raymond James 38th Annual Institutional Investors Conference
BETHLEHEM, Pa., Feb. 27, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Raymond James 38th Annual Institutional Investors Conference in Orlando, Florida.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on March 6, 2017, at approximately 8:40... 
Printer Friendly Version
02/24/17OraSure Technologies Announces Director Retirement
BETHLEHEM, Pa., Feb. 24, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Roger L. Pringle will be retiring as a member of the Company’s Board of Directors, effective May 16, 2017.  Mr. Pringle is the Company’s longest tenured Director, having served on the Board since September 2000.  Prior to that, Mr. Pringle served as Chairman of the Board and Director of one of the Company’s ... 
Printer Friendly Version
02/08/17OraSure Announces 2016 Fourth Quarter and Full-Year Financial Results
BETHLEHEM, Pa., Feb. 08, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the fourth quarter and full year ended December 31, 2016. Financial HighlightsConsolidated net revenues for the fourth quarter of 2016 were $35.5 million, a 10% increase from the fourth quarter of 2015. Consolidated net revenues for the year ended December 31, 2016 rose to ... 
Printer Friendly Version